Combination of serological biomarkers and clinical features to predict mucosal healing in Crohn’s disease: a multicenter cohort study

被引：0
|
作者：
Nana Tang
Han Chen
Ruidong Chen
Wen Tang
Hongjie Zhang
机构：
[1] The First Affiliated Hospital of Nanjing Medical University,Department of Gastroenterology
[2] The Second Affiliated Hospital of Soochow University,Department of Gastroenterology
来源：
BMC Gastroenterology | / 22卷
关键词：
Crohn’s disease; Mucosal healing; Nomogram; PLR; Endoscopic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Complete endoscopic healing is associated with lower disability than partial endoscopic healing in Crohn's disease: A prospective multicenter study
    Yzet, Clara
    Brazier, Franck
    Sebbagh, Virginie
    Vanelslander, Pierre
    Dejour, Valerie
    David, Blanche
    Nguyen-Khac, Eric
    Diouf, Momar
    Fumery, Mathurin
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (04)
  • [32] Mucosal healing in Crohn's disease and ulcerative colitis: what does it tell us?
    Flynn, Ann
    Kane, Sunanda
    CURRENT OPINION IN GASTROENTEROLOGY, 2011, 27 (04) : 342 - 345
  • [33] Diagnostic utility of serological biomarkers in patients with Crohn's disease: A case-control study
    Yao, Fang
    Fan, Yihong
    Lv, Bin
    Ji, Conghua
    Xu, Li
    MEDICINE, 2018, 97 (32)
  • [34] Subcutaneous Infliximab Concentration Thresholds for Mucosal and Transmural Healing in Patients With Crohn's Disease
    Hong, Sung Noh
    Song, Joo Hye
    Kim, Sung Jin
    Park, Yoon Ha
    Choi, Chang Wan
    Kim, Ji Eun
    Kim, Eun Ran
    Chang, Dong Kyung
    Kim, Young-Ho
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (02) : 313 - 322
  • [35] Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease: A Prospective Cohort Study
    Ma, Christopher
    Lumb, Rowan
    Walker, Emily V.
    Foshaug, Rae R.
    Dang, ThucNhi T.
    Verma, Sanam
    Huang, Vivian W.
    Kroeker, Karen I.
    Wong, Karen
    Dieleman, Levinus A.
    Fedorak, Richard N.
    Halloran, Brendan P.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (09) : 1643 - 1649
  • [36] Clinical features and predictors of clinical outcomes in Korean patients with Crohn's disease: A Korean Association for the Study of Intestinal Diseases multicenter study
    Moon, Chang Mo
    Park, Dong Il
    Kim, Eun Ran
    Kim, Young-Ho
    Lee, Chang Kyun
    Lee, Suck-Ho
    Kim, Jae Hak
    Huh, Kyu-Chan
    Jung, Sung-Ae
    Yoon, Soon Man
    Song, Hyun Joo
    Jang, Hyun Joo
    Kim, You Sun
    Lee, Kang-Moon
    Shin, Jeong Eun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (01) : 74 - 82
  • [37] Are Radiomic Spleen Features Useful for Assessing the Response to Infliximab in Patients With Crohn's Disease? A Multicenter Study
    Tang, Chao-Tao
    Yin, Fang
    Yin, Yitian
    Liu, Zide
    Long, Shunhua
    Zeng, Chun-Yan
    Chen, Yong
    Chen, You-Xiang
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2024, 15 (05)
  • [38] Prospective Evaluation of the Achievement of Mucosal Healing with Anti-TNF-α Therapy in a Paediatric Crohn's Disease Cohort
    Nuti, Federica
    Civitelli, Fortunata
    Bloise, Silvia
    Oliva, Salvatore
    Aloi, Marina
    Latorre, Giuseppe
    Viola, Franca
    Cucchiara, Salvatore
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (01) : 5 - 12
  • [39] Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study
    He, Yao
    Mao, Ren
    Chen, Fang
    Xu, Ping-Ping
    Chen, Bai-Li
    Wu, Yun
    Qiu, Yun
    Zhang, Sheng-Hong
    Feng, Rui
    Zeng, Zhi-Rong
    Ben-Horin, Shomron
    Chen, Min-Hu
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (05) : 397 - 406
  • [40] Feasibility of a Clinical Decision Support Tool for Ustekinumab to Predict Clinical Remission and Relapse in Patients With Crohn's Disease: A Multicenter Observational Study
    Park, Jihye
    Chun, Jaeyoung
    Yoon, Hyuk
    Cheon, Jae Hee
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (04) : 548 - 554
12345